Announcement on Resolutions of the 21st Meeting of the 5th Board of Directors

Securities code: 603309 Securities abbreviation: Weili Medical Announcement number: 2026-029 Guangzhou Weili Medical Equipment Co., Ltd.

Announcement of Resolutions of the 21st Meeting of the Fifth Board of Directors

The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.

1. Convening of board of directors meetings

The meeting notice and materials for the 21st meeting of the fifth board of directors of Guangzhou Weili Medical Equipment Co., Ltd. (hereinafter referred to as the "Company" and "Weili Medical") were issued by email on July 20, 2026. The meeting was held at 10 a.m. on July 30, 2026 in the company conference room. The meeting was held by a combination of on-site and communication methods. The meeting was chaired by Chairman Mr. Xiang Bin. Seven directors should be present at the meeting, and seven directors were present in person. Among them, independent director Mr. Lu Chunbin, independent director Mr. Ouyang Wenjin, and independent director Mr. Zang Chuanbao were on a business trip and participated in this meeting by communication voting. All senior managers of the company attended the meeting. The convening and holding procedures of this meeting complied with the relevant provisions of the Company Law and other relevant laws, administrative regulations, departmental rules, normative documents and the Articles of Association. The resolutions formed at the meeting were legal and valid.

2. Review status of board of directors meeting

(1) The "Full Text and Summary of the Company's 2026 Semi-Annual Report" was reviewed and approved; (The full text was published on the website of the Shanghai Stock Exchange (www.sse.com.cn) on the same day, and the summary was published on the same day on the "China Securities Journal", "Shanghai Securities News", "Securities Times" and the website of the Shanghai Stock Exchange (www.sse.com.cn))

The company's 2026 semi-annual financial report has been reviewed and approved at the 10th meeting of the Audit Committee of the fifth session of the board of directors.

Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.

(2) Consider and adopt the "Proposal on the General Election of Non-Independent Directors of the Sixth Board of Directors of the Company";

The term of the company's fifth board of directors is about to expire. According to the relevant provisions of the "Company Law" and the "Articles of Association", the board of directors needs to conduct a general election. The company's sixth board of directors plans to consist of 7 directors, including 1 employee director, 3 independent directors and 3 non-independent directors. After passing the qualification review by the Nomination Committee of the Company's Board of Directors, the Board of Directors agreed to nominate Mr. Xiang Bin, Mr. Han Guangyuan and Mr. Duan Songfeng as non-independent director candidates for the Company's sixth Board of Directors. The non-independent directors of the board of directors are elected by the shareholders' meeting and will form the company's sixth board of directors together with the independent directors elected by the shareholders' meeting and the employee directors elected by the employee congress. The term of office is three years, starting from the date of election by the shareholders' meeting. (For details, please refer to the "Vili Medical's Announcement on the General Election of the Board of Directors" published on the same day in "China Securities Journal", "Shanghai Securities News", "Securities Times" and the Shanghai Stock Exchange website (www.sse.com.cn) (Announcement No.: 2026-030))

Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.

The above matters have been reviewed and approved at the Nomination Committee meeting of the company's board of directors before the board meeting, and still need to be submitted to the company's first extraordinary shareholders' meeting in 2026 for review and approval.

(3) Consider and adopt the "Proposal on the General Election of Independent Directors of the Sixth Board of Directors of the Company";

The term of the company's fifth board of directors is about to expire. According to the relevant provisions of the "Company Law" and the "Articles of Association", the board of directors needs to conduct a general election. The company's sixth board of directors plans to consist of 7 directors, including 1 employee director, 3 independent directors and 3 non-independent directors. After passing the qualification review by the Nomination Committee of the company's board of directors, the board of directors agreed to nominate Mr. Lu Chunbin, Mr. Ouyang Wenjin and Mr. Zang Chuanbao as independent director candidates for the company's sixth board of directors. The independent directors of the board of directors are elected by the shareholders' meeting and will form the sixth session of the company's board of directors together with the non-independent directors elected by the shareholders' meeting and the employee directors elected by the employee congress. The term of office is three years, starting from the date of election by the shareholders' meeting. (For details, please refer to the "Vili Medical's Announcement on the General Election of the Board of Directors" published on the same day in "China Securities Journal", "Shanghai Securities News", "Securities Times" and the Shanghai Stock Exchange website (www.sse.com.cn) (Announcement No.: 2026-030))

Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.

The above matters have been reviewed and approved at the Nomination Committee meeting of the company's board of directors before the board meeting, and still need to be submitted to the company's first extraordinary shareholders' meeting in 2026 for review and approval.

(4) Review and approve the "Semi-annual Evaluation Report of the Company's 2026 "Improving Quality, Increasing Efficiency and Focusing on Returns" Action Plan"; (For details, please refer to the relevant content of the second part of Section 3 of "Weili Medical's 2026 Semi-Annual Report Full Text" "Discussion and Analysis of Operating Situations")

Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.

(5) Consider and adopt the "Proposal on Convening the Company's First Extraordinary Shareholders' Meeting in 2026".

The company plans to hold the company's first extraordinary shareholders meeting in 2026 at 14:30 pm on August 17, 2026 in the conference room on the second floor of the company's Building 1. (For details, please refer to the "Notice of Weili Medical on Convening the First Extraordinary Shareholders Meeting in 2026" published on the same day in "China Securities Journal", "Shanghai Securities News", "Securities Times" and the Shanghai Stock Exchange website (www.sse.com.cn) (Announcement No.: 2026-032))

Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.

Announcement is hereby made.

Board of Directors of Guangzhou Weili Medical Devices Co., Ltd.

July 31, 2026